Trial NCT01545427

View at ClinicalTrials.gov 
Org. Study IDs: R-07-214
Secondary IDs: #031-06

Last trial update was posted on 2012-03-07

MeSH Interventions

Imatinib Mesylate

MeSH Conditions

Scleroderma, Diffuse Scleroderma, Localized Scleroderma, Systemic

Other Conditions

Scleroderma

Stopping Reasons

Frequent adverse events occurred early in treatment with poor tolerability.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID